Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe Added to Statin Therapy (EASY)
NCT00395473Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 2005
- Primary completion
- Nov 2005
01
Overview
Phase 3, open-label, single-arm trial of ezetimibe in hypercholesterolemia, sponsored by Organon & Co. Primary endpoint: Percent reduction in plasma low-density lipoprotein cholesterol concentration at 6 weeks. Started Mar 2005; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00395473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395473.